Inhibition of calpains fails to improve regeneration through a peripheral nerve conduit  by Hausner, Thomas et al.
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Calpain  inhibitor  leupeptin  locally  applied  to  transected  sciatic  nerve  of rats.
Axon  number  and  myelination  not  signiﬁcantly  increased  3  months  after  lesion.
No  difference  in  behavioral  tests  after  nerve  regeneration.
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a  b  s  t  r  a  c  t
Intramuscular  injection  of  the  calpain  inhibitor  leupeptin  promotes  peripheral  nerve  regeneration  in pri-
mates  (Badalamente  et al., 1989  [13]), and  direct  positive  effects  of  leupeptin  on  axon  outgrowth  were
observed  in  vitro  (Hausott  et al.,  2012  [12]).  In this  study,  we  applied  leupeptin  (2 mg/ml)  directly  to
collagen-ﬁlled  nerve  conduits  in the  rat  sciatic  nerve  transection  model.  Analysis  of myelinated  axonseywords:
eupeptin
erve lesion
xotomy
ciatic nerve
eripheral nervous system
and  retrogradely  labeled  motoneurons  as well  as  functional  ‘CatWalk’  video  analysis  did  not  reveal  sig-
niﬁcant  differences  between  vehicle  controls  and  leupeptin  treated  animals.  Therefore,  leupeptin  does
not improve  nerve  regeneration  via  protease  inhibition  in  regrowing  axons  or in  surrounding  Schwann
cells  following  a single  application  to a  peripheral  nerve  conduit  suggesting  indirect  effects  on motor
endplate  integrity  if applied  systemically.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Damage to peripheral nerves often results in abortive or inad-
quate regeneration due to inappropriate or missing connections
etween the injured nerve stumps. Various factors are required for
uccessful regeneration in the peripheral nervous system, including
he re-establishment of continuity of the peripheral nerve path-
ays, the fast coaptation of nerve stump endings, and the ability
f axons, microglial and Schwann cells to react to signals that
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ars.klimaschewski@i-med.ac.at (L. Klimaschewski).
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304-3940/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open
icenses/by-nc-nd/3.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
initiate regeneration [1,2]. Moreover, the closely regulated system
of secreted proteases and protease inhibitors modiﬁes the extracel-
lular matrix and, thereby, allows axons to regenerate along newly
assembled glial scaffolds which guide them to their targets [3].
Endogenous and pharmacological inhibitors of proteases have
long been known to be potent modulators of neurite outgrowth.
Among these inhibitors, the small peptide leupeptin (N-acetyl-l-
leu-l-leu-arginal) inhibits the activity of calcium-activated neutral
proteases (CANPs or calpains), and serin proteases such as throm-
bin as well as proteasomal trypsin-like activities [4]. Calpains are
enzymes with high afﬁnity for cytoskeletal proteins such as neu-
roﬁlaments [5]. They have also been shown to cleave -spectrin,
collapsin response mediator protein-2, and voltage-gated sodium
channels [6].
 access article under the CC BY-NC-ND license (http://creativecommons.org/
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Direct administration of leupeptin to the sciatic nerve results
n increased glial proliferation, but demyelination of axons and
xon sprouting are observed, too [7–9]. Furthermore, this tripep-
ide promotes neurite outgrowth in neonatal and in adult sensory
euron culture [10–12]. Leupeptin also improves morphological
egeneration and functional recovery in vivo following a median
erve lesion if injected into target muscles combined with repeated
ystemic intramuscular administration over 6 months in primates
fter median nerve injury [13]. However, these studies did not
rovide an unequivocal answer to the clinically relevant question
hether local inhibition of calpains at the lesion site is able to
mprove axonal regeneration. Therefore, the aim of this study was
o analyze possible pro-regenerative effects of leupeptin locally
pplied to a nerve conduit bridging the gap between the endings of
 transected sciatic nerve in rats.
. Materials and methods
.1. Animals
Experiments were carried out on male Sprague–Dawley rats
eighing 300–350 g (Animal Research Laboratories, Austria). The
nimals were anesthetized by intraperitoneal administration of a
ombination of ketamine hydrochloride plus xylazine (ketamine
ydrochloride: 90 mg/kg body weight; xylazine: 5 mg/kg). Ade-
uate care was taken in all cases to minimize the levels of pain and
iscomfort during and after the operation, and the experimental
rotocol was approved in advance by the Animal Protocol Review
oard of the City Government of Vienna (No.: MA58-1020/2008/7).
ll procedures were carried out in full accordance with the Helsinki
eclaration on Animal Rights and the Guide for the Care and Use of
aboratory Animals of the National Institutes of Health.
In experimental and control animals (n = 10 for each group) the
ight sciatic nerve was exposed through a mid-thigh incision and
epaired by inserting the transected ends of the nerve into a 8 mm
ilicone conduit ﬁlled with a collagen solution (10 g/ml type I
at tail collagen, Sigma–Aldrich) containing leupeptin (2 mg/ml,
igma–Aldrich) or vehicle as a control. The distance between the
tumps was adjusted to 6 mm.  The internal diameter of the tube
easured 1.5 mm.  In another group of animals a 10 mm conduit
ith a gap size of 8 mm was used (n = 5 for each group). The
erve stumps were ﬁxed without tension by suturing each end
nto the open ends of the conduit by using 8-0 epineurial sutures
Ethilon 8-0/BV-2, Ethicon-Johnson & Johnson) under an operat-
ng microscope (Leica M651). The wound was closed and animals
ere housed in normal cages (two animals/cage). In control ani-
als (n = 10), the same procedure was performed but the conduits
ere ﬁlled with collagen only. The concentration of leupeptin used
ere was in the same range as in other in vivo studies [7,8], and
iological activity was conﬁrmed by measuring neurite outgrowth
nd receptor tyrosine kinase ﬂuorescence changes in cultured adult
ensory neurons as described before [12].
.2. Functional analysis
Functional analysis of the locomotor pattern was  performed
eekly through the use of the CatWalk automated gait analysis sys-
em (Noldus) starting 4 weeks after surgery. At every time point,
hree successful runs produced by each animal were recorded and
he results of these were averaged. The following parameters were
ssessed: footprint intensity (the maximum pressure exerted by
ne paw, expressed in arbitrary units, a.u.), footprint area (the mean
rea of each footprint of the affected hind limb, in mm2), stance
uration (the duration of the stance phase of the hind limb, in s),etters 566 (2014) 280–285 281
swing duration (the duration of the swing phase of the hind limbs,
in s) and swing speed (the speed of the swing phase, in cm/s).
2.3. Electrophysiological analysis
At the end of the survival period, electrophysiological analysis
(NeuroMax-XLTEK) was  carried out during the terminal operations
in all animals to assess the extent of reinnervation in the various
groups. Stimulation electrodes were placed 2 mm proximal and
2 mm  distal to the graft for calculation of the nerve conduction
velocity. A needle electrode was placed as a recording electrode into
the tibialis anterior muscle, and the sciatic nerve was  stimulated
for 0.05 ms  ﬁrst proximally and then distally to the graft in order to
achieve the supramaximal stimulation amplitude. The compound
action potential, the normalized amplitude and the nerve conduc-
tion velocity were determined. All measurements were carried out
at a body temperature between 38 and 39 ◦C.
2.4. Retrograde labeling and tissue preparation
After completing the electrophysiological recordings, the com-
mon  peroneal nerve on the operated side of animals in both
groups was  cut at the level of the tensor fasciae latae mus-
cle and Fast Blue crystals (Illing) were applied to the proximal
stump. The stump was  then thoroughly covered with two  lay-
ers of 1 mm thick Spongostan sheets to prevent diffusion of the
tracer. Five days were allowed for retrograde transport of the dye,
then the animals were re-anesthetized and perfused transcardi-
ally with ice-cold 0.9% heparinized saline solution followed by
4% phosphate-buffered paraformaldehyde (pH 7.4). The lumbar
spinal cord was carefully removed, postﬁxed in the same ﬁxative
overnight and cryo-protected in a 30% sucrose solution at 4 ◦C until
further use. The conduits containing the regenerated nerve were
explanted and postﬁxed in 2.5% phosphate-buffered glutaralde-
hyde for 24 h.
2.5. Morphological analysis
Remnants of ﬁxative were carefully washed out from the nerve,
and the tissue was next immersed in 1% OsO4 (Agar Scientiﬁc)
for 1 h, dehydrated in a graded ethanol series and in propylene
oxide and then embedded in Durcupan (Fluka). Semithin sections
(0.4 m)  were cut from the middle of the graft on a Leica Ultracut-R
ultramicrotome and stained according to Rüdeberg (1967). Mor-
phometric analysis was performed in a blind manner. Randomly
selected semithin section were used to assess the total cross-
sectional area of the whole nerve, the total ﬁber number, the
circle-ﬁtting diameter of the ﬁber, the axon myelin thickness and
the g-ratio through the use of MetaMorph® (Visitron).
To determine the number of retrogradely labeled motoneurons
supplying the common peroneal nerve, serial 25 m thick cryostat
sections were cut from the lumbar segments L3–L5. The sections
were mounted on gelatinized slides and examined by an Olym-
pus BX50 ﬂuorescence microscope. To avoid double counting of the
same neuron present in two consecutive sections, the retrogradely
labeled neurons were mapped with the aid of an Olympus drawing
tube and their locations were compared to those of labeled neurons
in the previous section. All sections from the L3–L5 motoneuron
pool were analyzed.
2.6. Statistical analysisThe statistical analysis was carried out with Graph Pad Prism sta-
tistical software. Groups were compared by use of ANOVA, followed
by Tukey’s post hoc test. Functional evaluations were analyzed
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Fig. 1. CatWalk automated gait analysis data 4–12 weeks postoperatively. No signiﬁcant differences were observed in various parameters indicating parallel restoration of
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. Results
.1. Functional observations
Detailed analysis of hindlimb function through the use of the
utomated gait analysis system CatWalk indicated moderate return
f function of hindlimb muscles throughout the 12 week obser-
ation period in both experimental groups. Parameters indicating
eturn of hindlimb function began to improve 6 weeks after injury
nd reached levels of typically over 50% of the pretraining val-
es (Fig. 1). Animals with conduits containing leupeptin revealed
lightly limited recovery in some of the parameters such as print
rea and maximum intensity, without showing statistically signif-
cant differences relative to the control animals (collagen only).
.2. Morphological observations
Twelve weeks after axotomy, conduits in both experimental
roups contained a regenerated segment of axon bundles connect-
ng the 6 mm gap between the proximal and distal nerve stumps
Fig. 2A). The cross sectional area at the middle of the regener-
te was compared. The area of control regenerates (collagen-ﬁlled
ubes) was slightly, but not signiﬁcantly greater relative to the
eupeptin-treated regenerates (0.24 ± 0.02 vs. 0.20 ± 0.01 mm2,
ig. 2B). Retrograde tracing by applying the ﬂuorescent tracer Fast
lue to the common peroneal nerve revealed considerable num-
ers of reinnervating motoneurons (Fig. 2C) in the control and
eupeptin-treated groups (587 ± 116 vs. 569 ± 66, Fig. 2D) without
igniﬁcant differences between the two groups.
The numbers of myelinated axons were also determined in
he regenerates (Figs. 3A and B), and these data correlated with
he motoneuron counts. Leupeptin-treated regenerates had fewer
yelinated axons as compared with control animals (7389 ± 853s. 5774 ± 848, Fig. 3C) indicating a non-signiﬁcant trend toward
educed axon numbers in the presence of leupeptin. Morpho-
etric analysis demonstrated no differences in myelin thickness
Fig. 3D) or axon diameter between control and leupeptin-treatedg are shown in the left part of each panel. Values are expressed as means ± S.E.M.
regenerates (Fig. 3E). However, the g-ratio (the ratio of the inner
axonal diameter relative to the outer diameter) was slightly, but
signiﬁcantly increased (Fig. 3F) suggesting a minor negative effect
of leupeptin on remyelination of axons as reported before [8]. The
trend toward smaller regenerates supports this assumption, too.
To exclude the possibility that leupeptin may  promote nerve
regeneration in a more severe injury paradigm the lesion exper-
iment and morphological analysis of sciatic nerves was  repeated
applying a 10 mm conduit with a gap size of 8 mm.  Following this
approach no signiﬁcant differences in number or myelination of
regenerated axons were observed either (data not shown).
3.3. Electrophysiological observations
Electrophysiological recordings were made from the tibialis
anterior muscle 3 months after surgery. Stimulating electrodes
were placed either proximal or distal to the nerve graft, and the con-
duction velocity within the grafted nerve segment was calculated.
At survival time of 3 months, considerable amplitude (19.7 ± 3.8
vs. 17.6 ± 6.4 mV)  and compound nerve action potential area values
(CNAP, 31.4 ± 5.7 vs. 27.4 ± 9.8 mV ms)  were observed in the con-
trol vs. leupeptin-treated animals (Fig. 4). These values did not differ
signiﬁcantly between the two experimental groups. More striking
but still non-signiﬁcant differences were detected in nerve conduc-
tion velocity values between the leupeptin-treated and the control
animals (40.2 ± 3.3 m/s  vs. 30.4 ± 6.7 m/s).
4. Discussion
The results of the present study suggest that a single applica-
tion of leupeptin into an artiﬁcial nerve conduit placed between
transected nerve stumps does not promote nerve regeneration and
re-innervation of target muscles. We  even observed a trend toward
reduction in number of regenerating motoneurons and in num-
ber of myelinated axons within the conduit as well as in myelin
thickness (without reaching statistical signiﬁcance at p < 0.05).The rationale of this study was based on previous ﬁndings that
leupeptin strongly promotes axon outgrowth if applied directly
to growth factor stimulated primary adult sensory neuron cul-
tures [10–12]. These cultures are nearly devoid of Schwann cells,
T. Hausner et al. / Neuroscience Letters 566 (2014) 280–285 283
Fig. 2. Axonal regeneration in control (collagen only) and leupeptin-treated peripheral nerve conduits 3 months after surgery. (A) The panel shows the macroscopic view of
the  established conduit (arrow) populated by regenerated axons in a control animal. (B) The cross sectional area of the conduit was non-signiﬁcantly smaller in leupeptin-
treated animals than in the controls. (C and D) Numerous retrogradely labeled motoneurons were found in the ventral horn of the L4–L5 spinal segments after labeling with
the  ﬂuorescent tracer Fast Blue from the common peroneal nerve (C). No signiﬁcant difference was observed between the experimental groups in the number of retrogradely
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owever. Considering the effects of leupeptin on Schwann cell pro-
iferation and myelin disruption in sciatic nerve branches with
ntact axons [8], the absence of effects on axon regeneration in
he sciatic nerve bridging model may  have been caused by this
nhibitory effect of leupeptin on axon remyelination. It has to
e pointed out, however, that a g-ratio of 0.6 as observed here
s still in the regular range of sciatic nerve axons (healthy or
egenerated).
Methodological differences to the study by Alvarez et al. [8]
ay  explain why myelin thickness only slightly decreased and
he g-ratio correspondingly increased following a single applica-
ion of leupeptin at the time of nerve transection as performed
ere. Alvarez et al. carried out repeated subperineurial injections
r continuous infusions of leupeptin (via a mini-osmotic pump)
nto the intact tibial nerve which may  have caused more prominent
ffects on non-neuronal cells. The inhibitory effects of leupeptin on
yelination could be successfully avoided by repeated intramus-
ular injections resulting in increased numbers of axons distal to
he lesion site which was accompanied by improved motor and
ensory conduction velocities and reduced muscle atrophy [13].
ince leupeptin has been shown to maintain neuromuscular con-
acts if directly applied to the muscle following nerve crush at birth
14], it appears likely that the primary site of action in the primatestudy [13] was within the denervated muscles and not within the
regenerating nerve.
However, chemoattractive effects of muscle-derived factors on
regenerating axons may  also underlie the improved morpholog-
ical outcome and enhanced conduction velocities, because intact
myoﬁbers are expected to release a plethora of trophic factors after
denervation [15]. The median nerve lesion in Badalamente’s study
was relatively close to the denervated muscles, which further sup-
ports this hypothesis.
The main pharmacological targets of leupeptin are calcium-
activated neutral proteases (calpains). Calpain activation plays a
key role not only in traumatic nerve injuries or stroke lesions, but
also in neurodegenerative diseases such as Alzheimer’s and Parkin-
son’s as well as in amyotrophic lateral sclerosis [16]. Calcium inﬂux,
as observed after nerve injury, leads to calpain activation, result-
ing in the cleavage of a variety of cellular substrates in neuronal
and non-neuronal cells. Considering the results of this study, the
effects of local calpain inhibition within a nerve conduit appear to
be minor and mainly involve Schwann cells that migrate into the
conduit, but not axons. In contrast, the effects on preventing muscle
denervation atrophy appear to be more signiﬁcant and may  war-
rant intramuscular injection of leupeptin as adjunctive treatment
for peripheral nerve repair.
284 T. Hausner et al. / Neuroscience Letters 566 (2014) 280–285
Fig. 3. Features of the regenerating axons in the peripheral nerve conduit. Photographs of semithin cross-sections from the middle of the conduit of control and leupeptin-
treated  animals (A and B) 3 months postoperatively. The control conduits (collagen only) contain more myelinated axons (C) with marginally thicker myelin sheaths (D),
while  the leupeptin-treated conduits appear to have slightly thicker axons (E), in a non-signiﬁcant manner. (F) The g-ratio is, however, higher in leupeptin-treated conduits as
compared with controls. * Signiﬁcant difference between the control and leupeptin groups, p < 0.05, by ANOVA, computed by using Tukey’s all pairwise multiple comparison
procedures. Values are expressed as means ± S.E.M.
Fig. 4. Electrophysiology stimulation data 3 months postoperatively. At the end of the survival period, the amplitude and CNAP values only marginally differ, whereas the
conduction velocity in the leupeptin-treated animals appear considerably lower than that in the collagen only group, without signiﬁcant difference. Values are expressed as
means ± S.E.M.
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